Barach Family Trust (CELU) reports warrants and convertible notes in Celularity Form 3
Rhea-AI Filing Summary
Celularity Inc disclosed that the Philip & Daniele Barach Family Trust, a more than ten percent owner, holds derivative positions tied to Celularity’s Class A common stock. The filing lists existing holdings rather than new purchases or sales.
The trust holds warrants exercisable at $2.00 per share for up to 839,160 underlying shares expiring on December 19, 2030, plus additional warrants for 3,707,457 underlying shares on the same terms. It also holds convertible notes with a conversion price of $1.66 per share for 1,204,819 underlying shares and another block for 1,807,229 shares, both convertible into Class A common stock through December 31, 2026. A footnote explains that up to $2,000,000 in aggregate principal amount of additional convertible notes may be purchased by the trust, with related warrants obtainable until June 19, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Convertible Notes | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Convertible Notes | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
Footnotes (1)
- Represents shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the "Additional Notes") that the Reporting Person has the option to purchase from the Issuer at any time until June 19, 2026. Represents shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of Additional Notes at any time until June 19, 2026.